Optomed

Optomed is a Finnish medical technology company founded in Finland in 2004, described as a leading provider of handheld fundus cameras globally. The company develops retinal imaging technology that it states is extensively patented and clinically validated, and its AI-powered screening solutions are designed to transform diagnostic processes and enable early detection. Optomed is a Finnish limited liability company headquartered in Oulu, Finland, with approximately 100 employees across the group and global operations. It is listed on the Nasdaq Helsinki stock exchange. Its product portfolio includes handheld and tabletop fundus cameras, AI-powered screening solutions, and ophthalmology software, with flagship offerings such as Optomed Lumo, Optomed Aurora IQ, Aurora AEYE, Smartscope PRO, and Optomed Polaris.

Optomed was founded in Finland in 2004, with the vision to design a cost-effective handheld fundus camera to improve the efficiency of eye screenings and to enable screening for all. The company describes itself as a Finnish medical technology company and a leading provider of handheld fundus cameras globally, with two decades of pioneering expertise in retinal imaging technology that it states is extensively patented and clinically validated. Its development focus has been on ease of use and high image quality, resulting in several patents and technology milestones such as the ISO10940 resolution of Smartscope PRO and the High-Contrast Optical Design of Optomed Aurora IQ. A significant breakthrough was reached in 2024 with Aurora AEYE, described as the First FDA-cleared Handheld AI Fundus Camera. In 2025 the next generation of portable retinal imaging was reached with the release of Optomed Lumo, a camera combining intuitive user experience, high-quality optics, seamless integration and data security in both handheld and tabletop form. Optomed is a Finnish limited liability company with headquarters in Oulu, Finland, and is listed on the Nasdaq Helsinki stock exchange.

Leading global provider of handheld fundus cameras; AI-powered screening solutions designed to transform diagnostic processes and enable early detection.

• Optomed Lumo

  Flagship product with AI integrations; non-mydriatic portable fundus camera for both handheld and tabletop use, with AI-assisted screening and programmable workflows, High-Contrast Optical Design with 12 MP resolution, seamless integration with DICOM connection, and data security with AES-256 encryption.

• Optomed Aurora IQ

  Portable retinal and eye surface imaging device designed for clinical versatility; non-mydriatic 50° field of view, High-Contrast Optical Design, retinal and anterior segment imaging.

• Aurora AEYE

  The first FDA-cleared handheld AI fundus camera for autonomous diabetic retinopathy detection; non-mydriatic 50° field of view, AI-screening of diabetic retinopathy, immediate screening result on camera; only available in the US.

• Smartscope PRO

  Compact and portable fundus camera for retinal and anterior eye imaging; non-mydriatic 40° field of view, retinal and anterior segment imaging.

• Optomed Polaris

  Tabletop fundus camera for automated retinal imaging for high-throughput clinical environments.

1. 1Handheld Fundus Camera for Retinal Screeningoptomed.com
2. 2About Optomedoptomed.com
3. 3Fundus Cameras & AI Screening | Optomedoptomed.com
4. 4Corporate governance - Optomedoptomed.com